Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Utility of a modified geriatric assessment to identify impairments in adults of all ages with lymphoma: A prospective observational cohort study.
Journal: Journal of geriatric oncology
Published: December 08, 2025
Primary Bone Lymphoma of the Jaw Masquerading as Infection and Delaying Treatment.
Journal: Hematology reports
Published: October 01, 2025
Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma.
Journal: British journal of haematology
Published: March 21, 2025
Racial differences in mycosis fungoides and Sézary syndrome: A multicenter cohort study.
Journal: Journal of the American Academy of Dermatology
Published: January 16, 2025
Comparison of standardized uptake value and standardized uptake lean body mass metrics in 18F-fluorodeoxyglucose positron emission tomography for assessing transformation in chronic lymphocytic leukemia and follicular lymphoma.
Journal: Quantitative imaging in medicine and surgery
Published: December 11, 2024
Long-term Update of a Phase 2 Study of Dose-Reduced Radiation in Diffuse Large B-Cell Lymphoma.
Journal: International journal of radiation oncology, biology, physics
Published: October 21, 2024
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.
Journal: Journal of the American Academy of Dermatology
Published: September 19, 2024
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.
Journal: Transplantation and cellular therapy
Published: August 25, 2024
The optimal management of relapsed and refractory Hodgkin lymphoma: post-brentuximab and checkpoint inhibitor failure.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 09, 2023
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study.
Journal: The Lancet. Haematology
Published: November 28, 2023
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas.
Journal: Journal for immunotherapy of cancer
Published: July 12, 2023
Last Updated: 09/26/2026